Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.

[1]  J. Gray,et al.  Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. , 2009, Journal of virological methods.

[2]  J. Gray,et al.  Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. , 2009, Journal of virological methods.

[3]  K. Edwards,et al.  Primary vaccine failure after 1 dose of varicella vaccine in healthy children. , 2008, The Journal of infectious diseases.

[4]  J. Gray,et al.  Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme Immunoassay , 2006, Clinical and Vaccine Immunology.

[5]  J. Heyse,et al.  Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection , 2002, The Pediatric infectious disease journal.

[6]  L. Saiman,et al.  Persistence of immunity to live attenuated varicella vaccine in healthy adults. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Seward.  UPDATE ON VARICELLA , 2001, The Pediatric infectious disease journal.

[8]  L. Saiman,et al.  Persistence of Immunity to Varicella-Zoster Virus After Vaccination of Healthcare Workers , 2001, Infection Control & Hospital Epidemiology.

[9]  P. LaRussa,et al.  Detection of antibodies to varicella-zoster virus using a latex agglutination assay. , 1994, Clinical and diagnostic virology.

[10]  W. Miller,et al.  Sensitive enzyme‐linked immunosorbent assay for antibody to varicella‐zoster virus using purified VZV glycoprotein antigen , 1990, Journal of medical virology.

[11]  P. LaRussa,et al.  Immunization of healthy adults with live attenuated varicella vaccine. , 1988, The Journal of infectious diseases.

[12]  P. Gerber,et al.  Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus , 1982, Journal of clinical microbiology.

[13]  C. Grose,et al.  Complement-enhanced neutralizing antibody response to varicella-zoster virus. , 1979, The Journal of infectious diseases.

[14]  A. Gershon,et al.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. , 1974, The Journal of infectious diseases.

[15]  J. Gray,et al.  Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.